Roy C. Cosan
President at Renova Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Paul A. Neeb | M | - |
RealBio Technology, Inc.
 RealBio Technology, Inc. BiotechnologyHealth Technology RealBio Technology, Inc. develops cell and tissue culture technologies. It introduced D4 Culture System-an advanced, disposable cell culture platform capable of developing full three-dimensional cell structures in vitro. The firm's D4 Culture System enables customers to develop cell structures that mimic the natural composition, configuration and function of normal and diseased tissue. The company was founded by Lee Noll in June 2009 and is headquartered in Kalamazoo, MI. | - |
| Olav Bergheim | M | 73 |
Fjord Ventures Inc
 Fjord Ventures Inc Investment ManagersFinance Fjord Ventures Inc (Fjord Ventures) is a venture capital firm founded in 2005 by Olav B. Bergheim. The firm is headquartered in Laguna Hills, California. | 19 years |
| H. Hammond | M | - |
Renova Therapeutics, Inc.
 Renova Therapeutics, Inc. BiotechnologyHealth Technology Renova Therapeutics, Inc. operates as a biopharmaceutical company. The firm is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. Its product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in patients with CHF. The company was founded by Jack W. Reich, H. Kirk Hammond and Craig Andrews in 2009 and is headquartered in San Diego, CA. | 15 years |
| Vijay Mahant | M | - |
Renova Therapeutics, Inc.
Renova Therapeutics, Inc. BiotechnologyHealth Technology Renova Therapeutics, Inc. operates as a biopharmaceutical company. The firm is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. Its product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in patients with CHF. The company was founded by Jack W. Reich, H. Kirk Hammond and Craig Andrews in 2009 and is headquartered in San Diego, CA. | 3 years |
| Daniel Bradbury | M | 62 |
Renova Therapeutics, Inc.
Renova Therapeutics, Inc. BiotechnologyHealth Technology Renova Therapeutics, Inc. operates as a biopharmaceutical company. The firm is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. Its product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in patients with CHF. The company was founded by Jack W. Reich, H. Kirk Hammond and Craig Andrews in 2009 and is headquartered in San Diego, CA. | 10 years |
| Michael Torres | M | - |
Renova Therapeutics, Inc.
Renova Therapeutics, Inc. BiotechnologyHealth Technology Renova Therapeutics, Inc. operates as a biopharmaceutical company. The firm is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. Its product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in patients with CHF. The company was founded by Jack W. Reich, H. Kirk Hammond and Craig Andrews in 2009 and is headquartered in San Diego, CA. | - |
| William Davidson | M | 73 |
Renova Therapeutics, Inc.
Renova Therapeutics, Inc. BiotechnologyHealth Technology Renova Therapeutics, Inc. operates as a biopharmaceutical company. The firm is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. Its product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in patients with CHF. The company was founded by Jack W. Reich, H. Kirk Hammond and Craig Andrews in 2009 and is headquartered in San Diego, CA. | - |
| Richard V. McCloskey | M | - |
Renova Therapeutics, Inc.
Renova Therapeutics, Inc. BiotechnologyHealth Technology Renova Therapeutics, Inc. operates as a biopharmaceutical company. The firm is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. Its product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in patients with CHF. The company was founded by Jack W. Reich, H. Kirk Hammond and Craig Andrews in 2009 and is headquartered in San Diego, CA. | 8 years |
| Jack Ball | M | 77 |
RealBio Technology, Inc.
RealBio Technology, Inc. BiotechnologyHealth Technology RealBio Technology, Inc. develops cell and tissue culture technologies. It introduced D4 Culture System-an advanced, disposable cell culture platform capable of developing full three-dimensional cell structures in vitro. The firm's D4 Culture System enables customers to develop cell structures that mimic the natural composition, configuration and function of normal and diseased tissue. The company was founded by Lee Noll in June 2009 and is headquartered in Kalamazoo, MI. | - |
| Kristen Apgar | F | - |
Fjord Ventures Inc
Fjord Ventures Inc Investment ManagersFinance Fjord Ventures Inc (Fjord Ventures) is a venture capital firm founded in 2005 by Olav B. Bergheim. The firm is headquartered in Laguna Hills, California. | 18 years |
| Tyler Kibbee | M | - |
Fjord Ventures Inc
Fjord Ventures Inc Investment ManagersFinance Fjord Ventures Inc (Fjord Ventures) is a venture capital firm founded in 2005 by Olav B. Bergheim. The firm is headquartered in Laguna Hills, California. | 14 years |
| John R. Trittschuh | M | - |
RealBio Technology, Inc.
RealBio Technology, Inc. BiotechnologyHealth Technology RealBio Technology, Inc. develops cell and tissue culture technologies. It introduced D4 Culture System-an advanced, disposable cell culture platform capable of developing full three-dimensional cell structures in vitro. The firm's D4 Culture System enables customers to develop cell structures that mimic the natural composition, configuration and function of normal and diseased tissue. The company was founded by Lee Noll in June 2009 and is headquartered in Kalamazoo, MI. | - |
| Andy Noorda | M | - |
Renova Therapeutics, Inc.
Renova Therapeutics, Inc. BiotechnologyHealth Technology Renova Therapeutics, Inc. operates as a biopharmaceutical company. The firm is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. Its product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in patients with CHF. The company was founded by Jack W. Reich, H. Kirk Hammond and Craig Andrews in 2009 and is headquartered in San Diego, CA. | - |
| James Planka | M | - |
RealBio Technology, Inc.
RealBio Technology, Inc. BiotechnologyHealth Technology RealBio Technology, Inc. develops cell and tissue culture technologies. It introduced D4 Culture System-an advanced, disposable cell culture platform capable of developing full three-dimensional cell structures in vitro. The firm's D4 Culture System enables customers to develop cell structures that mimic the natural composition, configuration and function of normal and diseased tissue. The company was founded by Lee Noll in June 2009 and is headquartered in Kalamazoo, MI. | - |
| Morgan Xu | M | - |
Renova Therapeutics, Inc.
Renova Therapeutics, Inc. BiotechnologyHealth Technology Renova Therapeutics, Inc. operates as a biopharmaceutical company. The firm is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. Its product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in patients with CHF. The company was founded by Jack W. Reich, H. Kirk Hammond and Craig Andrews in 2009 and is headquartered in San Diego, CA. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Lloyd M. Kunimoto | M | - |
Galileo Pharmaceuticals, Inc.
 Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | 4 years |
| Guy Miller | M | - |
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | 10 years |
| Julie Dove | F | - |
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | 6 years |
| Fred Craves | M | 78 |
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | - |
| Dave Starkey | M | - |
Western Michigan University
| 4 years |
| Kenneth Stephens | M | - |
Western Michigan University
| 3 years |
| Mark D. Nemec | M | - |
Western Michigan University
| 4 years |
| Mohamed Fadzli bin Ibrahim | M | 68 |
Western Michigan University
| 4 years |
| Charles P. Hart | M | - |
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | 3 years |
| Jack Butler | M | - |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | 7 years |
| Carolyn Cassin | F | - |
Western Michigan University
| 2 years |
| Mohammad Ibrahim Al-Mansour | M | - |
Western Michigan University
| 4 years |
| Joe Zbikowski | M | - |
Western Michigan University
| 2 years |
| Daniel Paul Regan | M | 60 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | 8 years |
| Bruce A. Hammack | M | 71 |
Western Michigan University
| 4 years |
| Paul Neilson | M | 68 |
Western Michigan University
| 4 years |
| Deborah Joyce Tallman | F | - |
Western Michigan University
| 4 years |
| Mary Baker | F | 65 |
Western Michigan University
| 4 years |
| Chris Copps | M | - |
Western Michigan University
| 5 years |
| John Michael Dankovich | M | - |
Western Michigan University
| 4 years |
| Xiao Bing Li | M | 56 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | 14 years |
| Mohammad Nordin bin Mohammad Zain | M | 67 |
Western Michigan University
| 4 years |
| Debi Watson | F | - |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | 22 years |
| Terry E. McSween | M | - |
Western Michigan University
| 3 years |
| Gloria Pfister | M | - |
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | 6 years |
| Laurie A. Macaddino | F | - |
Western Michigan University
| 4 years |
| Jennifer A. Spinella | F | - |
Renova Therapeutics, Inc.
Renova Therapeutics, Inc. BiotechnologyHealth Technology Renova Therapeutics, Inc. operates as a biopharmaceutical company. The firm is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. Its product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in patients with CHF. The company was founded by Jack W. Reich, H. Kirk Hammond and Craig Andrews in 2009 and is headquartered in San Diego, CA. | 3 years |
| Thomas White | M | 66 |
Western Michigan University
| 4 years |
| Bryan D. Farnsworth | M | 66 |
Western Michigan University
| 4 years |
| David Norton | M | 72 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | 1 years |
| Craig C. Taylor | M | 74 |
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | 10 years |
| Peter Morris | M | - |
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | 7 years |
| Zoltan Bognar | M | 60 |
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | 5 years |
| David J. Schadler | M | - |
Western Michigan University
| 4 years |
| David Dombrowski | M | - |
Western Michigan University
| 4 years |
| Hugh A. Neuharth | M | - |
Fjord Ventures Inc
Fjord Ventures Inc Investment ManagersFinance Fjord Ventures Inc (Fjord Ventures) is a venture capital firm founded in 2005 by Olav B. Bergheim. The firm is headquartered in Laguna Hills, California. | 15 years |
| Lisa Zanetto | F | - |
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | 6 years |
| David Liebowitz | M | - |
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | 4 years |
| Drew S. Jones | M | - |
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | 3 years |
| Gregory S. Wagner | M | - |
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | 1 years |
| Terrance McGovern | M | - |
Fjord Ventures Inc
Fjord Ventures Inc Investment ManagersFinance Fjord Ventures Inc (Fjord Ventures) is a venture capital firm founded in 2005 by Olav B. Bergheim. The firm is headquartered in Laguna Hills, California. | 6 years |
| Thomas Sweet | M | 64 |
Western Michigan University
| 4 years |
| Mark A. Stern | M | - |
Western Michigan University
| 4 years |
| Bill Burkoth | M | 47 |
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | 1 years |
| Richard Aderman | M | - |
Western Michigan University
| 4 years |
| David Milligan | M | 83 |
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | 7 years |
| William Foster | M | - |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | 10 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 62 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Roy C. Cosan
- Personal Network
